a novel methionine adenosyltransferase 2A (MAT2A)-inhibitor being explored for solid tumors. SYH2039 targets solid tumors that have a mutation called MTAP deletion, which is estimated to be ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback